| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:42 | Charles River, American Heart Association Partner to Advance Cardiovascular Health Awareness | ||
| Do | Altruist Biologics' Hangzhou Facility Gets First Commercial-Scale Manufacturing License | ||
| Do | Glenmark Gets FDA Approval for Bioequivalent Progesterone Vaginal Insert | ||
| Do | Thermo Fisher, Singapore's PRECISE Partner on Population-Scale Proteomics Biobank | ||
| Do | Touchlight, SVF Vaccines Partner to Advance Hepatitis B/D Vaccine | ||
| Do | Cartherics, Catalent Expand Partnership | ||
| Do | Byondis Names New CEO | ||
| Mi | Daiichi Sankyo Partnering With ATLATL Innovation Center to Accelerate APAC Biotech Innovation | ||
| Mi | Flow Sciences Taps Board Member Michael Gesser as New CFO | ||
| Mi | Ofichem Consolidates CDMO & Pharma Brands Under Single Ofichem Identity | ||
| Mi | Panthera Relocates to Health Innovation Hub | ||
| Mi | Frederic Desdouits Appointed CEO of Orano Med | ||
| Mi | GSK Wins China Approval for Exdensur in Nasal Polyps | ||
| Mi | Vion Biosciences Acquires Cellular Technology Limited | ||
| Di | Veradigm to Appoint Christian Greyenbuhl as Chief Financial Officer | ||
| Di | Valeris Appoints Scott Filosi Chief Commercial Officer | ||
| Di | Biocon Launches Two Denosumab Biosimilars, Aukelso and Bosaya, in US | ||
| Di | BASF Announces Up to 20% Price Increase for Excipients and APIs | ||
| Di | AC Immune, Lilly Amend Morphomer Tau Alliance | ||
| Di | Allucent Expands Specialty CRO Focus Across Oncology, Neuro, CGT | ||
| Di | Gilead Sciences Agrees to Acquire Tubulis | ||
| Di | Halozyme Hypercon, Vertex Pharmaceuticals Enter Exclusive Collab & License Agreement | ||
| Mo | GC Biopharma Validates Proprietary Technology to Mitigate Thromboembolic Risks | ||
| Mo | Akari Therapeutics Partners with WuXi XDC to Accelerate Development of Novel PH1 Payload | ||
| Mo | Thermo Fisher Introduces Gibco CTS Compleo Fill and Finish System |